HNGE Hinge Health, Inc.

NYSE www.hingehealth.com


$ 44.85 $ 0.06 (0.13 %)    

Thursday, 20-Nov-2025 15:20:25 EST
QQQ $ 589.58 $ -22.10 (-3.61 %)
DIA $ 460.23 $ -6.44 (-1.38 %)
SPY $ 656.61 $ -16.29 (-2.42 %)
TLT $ 89.21 $ 0.21 (0.24 %)
GLD $ 375.11 $ -0.06 (-0.02 %)
$ 44.1
$ 45.00
$ 44.86 x 400
$ 44.91 x 12
$ 44.80 - $ 47.05
$ 33.42 - $ 62.18
5,591,938
na
3.48B
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $61 t...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $62 to $65.

Core News & Articles

Piper Sandler analyst Jessica Tassan reiterates Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from ...

Core News & Articles

Hinge Health (NYSE:HNGE) raises FY2025 sales outlook from $548.000 million-$552.000 million to $572.000 million-$574.000 millio...

Core News & Articles

Hinge Health (NYSE:HNGE) sees Q4 sales of $155.000 million-$157.000 million vs $145.468 million analyst estimate.

Core News & Articles

Hinge Health (NYSE:HNGE) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.15) by...

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $63 to $66.

Core News & Articles

Baird analyst Vikram Kesavabhotla initiates coverage on Hinge Health (NYSE:HNGE) with a Neutral rating and announces Price T...

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $52 t...

Core News & Articles

JMP Securities analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target ...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $51 to $62.

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION